Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masafumi Umekage

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Inflammation and Regeneration|September 10, 2019
Overview: an iPS cell stock at CiRAMasafumi Umekage, Yoshiko Sato, Naoko Takasu
Plos One|February 4, 2014
L1cam is crucial for cell locomotion and terminal translocation of the Soma in radial migration during murine corticogenesisMadoka Tonosaki, Kyoko Itoh, Masafumi Umekage, et al.
Molecular Neurobiology|January 20, 2012
The shortest isoform of dystrophin (Dp40) interacts with a group of presynaptic proteins to form a presumptive novel complex in the mouse brainTakenori Tozawa, Kyoko Itoh, Takeshi Yaoi, et al.
Cytotherapy|September 7, 2023
Size control of induced pluripotent stem cells colonies in two-dimensional culture for differentiation into functional monocyte-like cellsNoriko Shimasaki, Eiko Shimizu, Yuta Nakamura, et al.
Journal of Neuroscience Research|October 18, 2012
Downregulation of L1 perturbs neuronal migration and alters the expression of transcription factors in murine neocortexTomokazu Kishimoto, Kyoko Itoh, Masafumi Umekage, et al.
Med (New York, N.Y.)|November 17, 2022
A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese populationShinsuke Yoshida, Tomoaki M Kato, Yoshiko Sato, et al.
Nature Communications|July 8, 2020
Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's diseaseDaisuke Doi, Hiroaki Magotani, Tetsuhiro Kikuchi, et al.
Molecular Therapy. Methods & Clinical Development|June 27, 2022
Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical applicationYuko Kitano, Sayaka Nishimura, Tomoaki M Kato, et al.
Elife|November 12, 2024
Complete suspension culture of human induced pluripotent stem cells supplemented with suppressors of spontaneous differentiationMami Matsuo-Takasaki, Sho Kambayashi, Yasuko Hemmi, et al.
The New England Journal of Medicine|March 16, 2017
Autologous Induced Stem-Cell-Derived Retinal Cells for Macular DegenerationMichiko Mandai, Akira Watanabe, Yasuo Kurimoto, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Inflammation and Regeneration|September 10, 2019
Overview: an iPS cell stock at CiRAMasafumi Umekage, Yoshiko Sato, Naoko Takasu
Plos One|February 4, 2014
L1cam is crucial for cell locomotion and terminal translocation of the Soma in radial migration during murine corticogenesisMadoka Tonosaki, Kyoko Itoh, Masafumi Umekage, et al.
Molecular Neurobiology|January 20, 2012
The shortest isoform of dystrophin (Dp40) interacts with a group of presynaptic proteins to form a presumptive novel complex in the mouse brainTakenori Tozawa, Kyoko Itoh, Takeshi Yaoi, et al.
Cytotherapy|September 7, 2023
Size control of induced pluripotent stem cells colonies in two-dimensional culture for differentiation into functional monocyte-like cellsNoriko Shimasaki, Eiko Shimizu, Yuta Nakamura, et al.
Journal of Neuroscience Research|October 18, 2012
Downregulation of L1 perturbs neuronal migration and alters the expression of transcription factors in murine neocortexTomokazu Kishimoto, Kyoko Itoh, Masafumi Umekage, et al.
Med (New York, N.Y.)|November 17, 2022
A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese populationShinsuke Yoshida, Tomoaki M Kato, Yoshiko Sato, et al.
Nature Communications|July 8, 2020
Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's diseaseDaisuke Doi, Hiroaki Magotani, Tetsuhiro Kikuchi, et al.
Molecular Therapy. Methods & Clinical Development|June 27, 2022
Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical applicationYuko Kitano, Sayaka Nishimura, Tomoaki M Kato, et al.
Elife|November 12, 2024
Complete suspension culture of human induced pluripotent stem cells supplemented with suppressors of spontaneous differentiationMami Matsuo-Takasaki, Sho Kambayashi, Yasuko Hemmi, et al.
The New England Journal of Medicine|March 16, 2017
Autologous Induced Stem-Cell-Derived Retinal Cells for Macular DegenerationMichiko Mandai, Akira Watanabe, Yasuo Kurimoto, et al.
Pageof 1